Vicarious Surgical (RBOT) EPS (Basic) Growth (1y) (2021 - 2025)
Vicarious Surgical (RBOT) EPS (Basic) Growth (1y) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -18.87% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 13.56% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 18.90% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 97.93% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 92.23% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -29.95% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 114.97% |
| 10 | Vicarious Surgical | 625,212.51 | -9.17 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 35.89% |
| Jun 30, 2025 | 14.04% |
| Mar 31, 2025 | 10.49% |
| Dec 31, 2024 | 12.18% |
| Sep 30, 2024 | 4.61% |
| Jun 30, 2024 | 28.54% |
| Mar 31, 2024 | 54.67% |
| Dec 31, 2023 | 2.18% |
| Sep 30, 2023 | 50.09% |
| Jun 30, 2023 | -908.38% |
| Mar 31, 2023 | -164.04% |
| Dec 31, 2022 | -116.71% |
| Sep 30, 2022 | 82.28% |
| Jun 30, 2022 | 84.15% |
| Mar 31, 2022 | 657.58% |
| Dec 31, 2021 | 861.53% |
| Sep 30, 2021 | -1,105.05% |
| Jun 30, 2021 | -2,022.37% |